Literature DB >> 20437542

The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.

Gilles Fénelon1, Thierry Soulas, Franck Zenasni, Laurent Cleret de Langavant.   

Abstract

New criteria for Parkinson's disease-associated psychosis (PDAP) were recently proposed by a NINDS-NIMH working group. We assessed 116 consecutive unselected outpatients with PD for the existence of psychotic symptoms during the previous month, using a structured questionnaire covering the whole spectrum of PDAP symptoms. Hallucinations occurred in 42% of the patients (visual: 16%; nonvisual: 35%), delusions in 4%, and minor symptoms in 45% (sense of presence, visual illusions, or passage hallucinations). The prevalence of PDAP was 43% when the usual definition was used (hallucinations and/or delusions) and 60% when the NINDS-NIHM criteria were used. Correlations between PDAP and patient characteristics varied with the definition of PDAP. These findings suggest that the epidemiology of PDAP should be re-evaluated with the new criteria. Minor symptoms and nonvisual hallucinations are an important part of the PDAP spectrum, which has commonly been restricted to visual hallucinations and delusions. 2010 Movement Disorder Society

Entities:  

Mesh:

Year:  2010        PMID: 20437542      PMCID: PMC2891710          DOI: 10.1002/mds.22839

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.

Authors:  Daniel Collerton; Elaine Perry; Ian McKeith
Journal:  Behav Brain Sci       Date:  2005-12       Impact factor: 12.579

Review 2.  Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.

Authors:  Stéphane Thobois
Journal:  Clin Ther       Date:  2006-01       Impact factor: 3.393

3.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

Authors:  G Fénelon; F Mahieux; R Huon; M Ziégler
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

4.  Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.

Authors:  Bernard Ravina; Karen Marder; Hubert H Fernandez; Joseph H Friedman; William McDonald; Diane Murphy; Dag Aarsland; Debra Babcock; Jefferey Cummings; Jean Endicott; Stewart Factor; Wendy Galpern; Andrew Lees; Laura Marsh; Mark Stacy; Katrina Gwinn-Hardy; Valerie Voon; Christopher Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.

Authors:  Claudio Pacchetti; Raffaele Manni; Roberta Zangaglia; Francesca Mancini; Enrico Marchioni; Cristina Tassorelli; Michele Terzaghi; Maria Ossola; Emilia Martignoni; Arrigo Moglia; Giuseppe Nappi
Journal:  Mov Disord       Date:  2005-11       Impact factor: 10.338

7.  Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.

Authors:  Kelvin L Chou; Susan Messing; David Oakes; Peter D Feldman; Alan Breier; Joseph H Friedman
Journal:  Clin Neuropharmacol       Date:  2005 Sep-Oct       Impact factor: 1.592

Review 8.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model.

Authors:  Nico J Diederich; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

Review 9.  When a Parkinson's disease patient starts to hallucinate.

Authors:  Werner Poewe
Journal:  Pract Neurol       Date:  2008-08

Review 10.  Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.

Authors:  Gilles Fénelon
Journal:  CNS Spectr       Date:  2008-03       Impact factor: 3.790

View more
  54 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

2.  Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.

Authors:  Maiya R Geddes; Yanmei Tie; John D E Gabrieli; Scott M McGinnis; Alexandra J Golby; Susan Whitfield-Gabrieli
Journal:  Cortex       Date:  2015-11-05       Impact factor: 4.027

Review 3.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Progress Regarding Parkinson's Disease Psychosis: It's No Illusion.

Authors:  Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2016-08-11

Review 5.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Authors:  Joel Mack; Peter Rabins; Karen Anderson; Susanne Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Gregory Pontone; Howard Weiss; James R Williams; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

Review 7.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

8.  Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease.

Authors:  O Grau-Rivera; E Gelpi; M J Rey; F Valldeoriola; E Tolosa; Y Compta; M J Martí
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

Review 9.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

10.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.